Asymmetrie endoscopie inflammation of the ileal pouch: A sign of ischemic pouchitis?

Inflammatory Bowel Diseases

Volumn 16, Issue 5, 2010, Pages 836-846

  Shen, Bo ^a,b   Plesec, Thomas P ^a   Remer, Erick ^a   Kiran, Pokala ^a   Remzi, Feza H ^a   Lopez, Rocio ^a   Fazio, Victor W ^a   Goldblum, John R ^a  

^a Digestive Disease Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Ileal pouch; Ischemia; Pouchitis; Restorative proctocolectomy

Indexed keywords

ALLOPURINOL; ANTICOAGULANT AGENT; BILIRUBIN; CIPROFLOXACIN; CORTICOSTEROID; HEMOSIDERIN; MESALAZINE; METRONIDAZOLE; RIFAXIMIN; TINIDAZOLE; ANTIINFECTIVE AGENT;

ABDOMINAL SURGERY; ADULT; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DEMOGRAPHY; DIGESTIVE TRACT ENDOSCOPY; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; HISTOPATHOLOGY; HUMAN; ILEITIS; ILEOSTOMY; ILEUM DISEASE; ILEUM POUCH; INTERMETHOD COMPARISON; INTESTINE ISCHEMIA; ISCHEMIA; ISCHEMIC POUCHITIS; MALE; METAPLASIA; PHENOTYPE; PORTAL VEIN THROMBOSIS; POSTOPERATIVE THROMBOSIS; POUCH FAILURE; PRIORITY JOURNAL; PYLORIC GLAND METAPLASIA; STOMACH BIOPSY; SUTURE; TREATMENT RESPONSE; COHORT ANALYSIS; COLON POUCH; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; SURVIVAL RATE; VASCULARIZATION;

ADULT; ANTI-BACTERIAL AGENTS; COHORT STUDIES; COLONIC POUCHES; CROHN DISEASE; ENDOSCOPY; FEMALE; HUMANS; ISCHEMIA; MALE; POUCHITIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77950651608     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21129     Document Type: Article

References (52)

1. 1. Duffy M, O'Mahony L, Coffey JC, et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial, adenomatous polyposis. Dis Colon Rectum. 2002;45:384-388. (Pubitemid 34273621)
2. Nasmyth DG, Godwin PGR, Dixon MF, et al. Ileal ecology after pouch anal anastomosis or ileostomy. Gastroenterology. 1989;96:817-824.
3. 3. Komanduri S, Gillevet PM, Sikaroodi M, et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol. Hepatol. 2007;5:352-360. (Pubitemid 46401536)
4. 4. Sokol H, Lay C, Seksik P, et al. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm. Bowel Dis. 2008; 14:858-867. (Pubitemid 351898071)
5. Ruseler-van Embden JG, Schouten WR, et al. Pouchitis: result of microbial. imbalance? Gut. 1994;35:658-664.
6. Gosselink MP, Schouten WR, van Lieshout LM, et al. Eradication of pathogenic bacteria and restoration of normal pouch flora; comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum. 2004;47:1519-1525.
7. Sandborn. WJ, Pouchitis: risk factors, frequency, natural history, classification and public health prospective. In: MeLeod RS, Martin F, Sutherland LR, et al, eds. Trends in Inflammatory Bowel Disease 1996. Lancaster, UK: Kluwer Academic; 1997:51-63.
8. Shen B. Diagnosis and management of patients with pouchitis. Drugs. 2003;65:453-461.
9. 9. Mann SD, Pitt J, Springall RG, et al. Clostridium difficile infectionan unusual, cause of refractory pouchitis: report of a case. Dis Colon Rectum. 2003;46:267-270. (Pubitemid 36222627)
10. Shen B, Goldblum JR., Hull TL, et al. Clostridium difficile-associated pouchitis. Dig Dis Sci. 2006;51:2361-2364
11. 11. Munoz-Juarez M, Pemberton JH, Sandborn WJ, et al. Misdiagnosis of specific cytomegalovirus infection of ileoanal, pouch as a refractory idiopathic chronic pouchitis. Report of two cases. Dis Colon Rectum. 1999;42:117-120. (Pubitemid 29053131)
12. 12. Mooka D, Furth EE, MacDermott RP, et al. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol, 1998;93:264-266. (Pubitemid 29063981)
13. 13. Shen B, Fazio VW, Remzi FH, et al. Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:81-89. (Pubitemid 43129528)
14. Shen B, Remzi FH, Bennett AE, et al, Association between immuneassociated disorders and adverse outcomes of ileal pouch-anal anastomosis. Am J Gastroenterol. 2009;104:655-664.
15. 15. Kienle P, Weitz J, Reinshagen S, et al. Association of decreased perfusion of the ileoanal pouch mucosa with early postoperative pouchitis and local septic complications. Arch Surg. 2001;136:1124-1130. (Pubitemid 32929338)
16. 16. Shen B, Fazio VW, Remzi FH, et al. Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the pouch. Dis Colon Rectum. 2007;50:1450-1459. (Pubitemid 47472395)
17. 17. Shen B, Fazio VW, Remzi FH, et al. Comprehensive evaluation of inflammatory and non-inflammatory sequelae of ileal, pouch-anal, anastomosis. Am J Gastroenterol. 2005;100:93-101. (Pubitemid 41623275)
18. Shen B, Remzi FH, Lavery IC, et al. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol, 2008;6: 145-158.
19. Sandborn. WJ, Tremaine WJ, Batts KP, et al, Pouchitis after ileal, pouch-anal anastomosis: A pouchitis disease activity index. Mayo Clin Proc. 1994;69:409-415.
20. 20. Aisenberg J, Legnani PE, Nilubol N, et al. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol, 2004; 99:432-441. (Pubitemid 38524119)
21. 21. Meier CB, Hegazi. RA, Aisenberg J, et al, Innate immune receptor genetic polymorphisms in pouchitis: is CARD 15 a susceptibility factor? Inflamm Bowel Dis. 2005;11:965-971. (Pubitemid 41580009)
22. 22. Sandborn W. Pouchitis following ileal pouch-anal anastomosis: Definition, pathogenesis, and treatment. Gastroenterologv. 1994;107:1856-1860. (Pubitemid 124006527)
23. Gosselink MP, Schouten WR, van Lieshout LMC, et al. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum. 2004;47:876-884.
24. 24. Gionchetti. P, Rizzello F, Venturi. A, et al, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a doubleblind, placebo-controlled trial. Gastroenterology. 2000;119:305-309. (Pubitemid 30621980)
25. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3®for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108-114.
26. Patel RT, Bain I, Youngs D, et al. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum. 1995;38: 831-837.
27. Schmidt C, Giese T, Ludwig B, et al. Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis. 2006;21:419-426.
28. 28. Gionchetti. P, Campieri. M, Belluzzi A, et al, Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches. Dig Dis Sci. 1994;39:1525-1531. (Pubitemid 2120471)
29. Shepherd NA, Healey CJ, Warren BF, et al. Distribution of mucosal, morphology and an assessment of colonic phenotype change in the pelvic ileal reservoir. Gut. 1993;34:101-105.
30. 30. Biancone L, Palmieri G, Lombardi A, et al. Tropomyosin expression in the ileal, pouch: a relationship with the development of pouchitis in ulcerative colitis. Am J Gastroenterol. 2003;98:2719-2726. (Pubitemid 38020114)
31. 31. Hallbook O, Johansson K, Sjodahl R. Laser Doppler blood flow measurement in rectal resection for carcinoma: comparison between the straight and colonic J pouch reconstruction. Br J Surg. 1996;83:389-392. (Pubitemid 126422868)
32. 32. Perbeck L, Lindquist K, Proano E, et al. Correlation between fluorescein flowmetry and laser Doppler flowmetry. A. study in the intestine (ileoanal pouch) in man. Scand J Gastroenterol. 1990:25: 520-524. (Pubitemid 20208217)
33. 33. Benoist S, Panis Y, Alves A, Valleur P. Impact of obesity on surgical outcomes after colorectal resection. Am J Surg. 2000;179: 275-281. (Pubitemid 30394688)
34. Kiran RP, Remzi FH, Fazio VW, et al. Complications and functional results after ileoanal pouch formation in obese patients. J Gastrointest Surg. 2008;12:668-674.
35. 35. Laake KO, Line PD, Aabakken L, et al. Assessment of mucosal, inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Scand J Gastroenterol. 2003;38:409-414. (Pubitemid 36606311)
36. Volk EE, Shapiro BD, Easley KA, et al. The clinical significance of a biopsy-based diagnosis of focal active colitis: a clinicopathologic study of 31 cases. Mod Pathol. 1998;11:789-794.
37. 37. Laake KO, Line PD, Grzyb K, et al. Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-analanastomosis (IPAA). Scand J Gastroenterol. 2004;39:1228-1235. (Pubitemid 39656838)
38. Thiriby RC. Optimizing results and techniques of mesenteric lengthening in ileal, pouch-anal anastomosis. Am J Surg. 1995;169:499-502.
39. 39. Cherqui D, Valleur P, Perniceni T, et al. Inferior reach of ileal reservoir in ileoanal anastomosis: experimental anatomic and angiographic study. Dis Colon Rectum. 1987;30:365-371. (Pubitemid 17078521)
40. Simchuk EJ, Thiriby RC. Risk factors and true incidence of pouchitis in patients after ileal, pouch-anal anastomoses. World J Surg. 2000;24;851-856.
41. 41. Ball C, MacLean AR, Buie WD, et al. Portal vein thrombi after ileal pouch-anal anastomosis: its incidence and association with pouchitis. Surg Today. 2007;37:552-557. (Pubitemid 46998952)
42. Mitsudo S, Brandt LJ. Pathology of intestinal ischemia. Surg Clin North Am. 1992;72:43-63.
43. Price AB. Ischaemic colitis. Curr Top Pathol. 1990;81:229-246.
44. Oikonomou IK, Fazio VW, Remzi FH, et al. Risk factors for anemia in patients with ileal pouch-anal anastomosis. Dis Colon Rectum. 2007;50:69-74.
45. Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn's disease. Gut. 2008;57:1-4.
46. Villanacci V, Bassotti G, Nascimbeni R, et al. Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil. 2008;20:1009-1016
47. Mitsudo S; Brandt LJ. Pathology of intestinal ischemia. Surg Clin North Am. 1992;72:43-63.
48. 48. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Prot: Natl Acad Sci U S A. 1990;87: 1620-1624. (Pubitemid 20080360)
49. 49. Joelsson M, Andersson M., Bark T, et al. Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study. Scand J Gastroenterol, 2001;36:1179-1184. (Pubitemid 32917587)
50. El Muhtaseb MS, Talwar D, Duncan A, et al. Free radical activity and lipid soluble anti-oxidant vitamin status in patients with long-term ileal pouch-anal anastomosis. Colorectal Dis. 2009;11:67-72.
51. Shebani KO, Stucchi AF, McClung JP, et al. Role of stasis and oxidative stress in ileal pouch inflammation. J Surg Res. 2000;90:67-75.
52. Levin KE, Pembeiton JH, Phillips SF, et al. Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum. 1992;35: 452-456.